← Back

AVE Science & Technology Co Ltd

AVE Science & Technology Co., Ltd. researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis networks, computer software, automatic control devices, and medical auxiliary equipment. Its products include urine formed elements analyzers and related reagents, automatic urine analyzers, multi-function microscopy analyzers, semi-automatic biochemical analyzers, feces analyzers, and vaginal secretion analyzers, as well as reagent packs, test strips, urine analyzer cleansers, urine sample collectors, and quality control products for urine formed elements analyzers. The company serves customers in China, Europe, the United States, Asia, Africa, and other international markets. Incorporated in 2000, it is headquartered in Changsha, China.

Price · split & dividend adjusted
News & notes moving 688067.CG
688067.CG2

Ave Science & Technology Releases 2026 Interim Report with Net Profit of 17.6824 Million Yuan

Ave Science & Technology released its 2026 interim report on August 28, 2026. During the reporting period, the company achieved total operating revenue of 113 million yuan and net profit attributable to the parent company of 17.6824 million yuan. Net cash inflow from operating activities was 3.9018 million yuan, a decrease of 6.8891 million yuan compared with the same period last year, down 63.84 percent year on year. The company's latest asset-liability ratio was 16.93 percent, gross margin was 59.58 percent, return on equity was 3.37 percent, and diluted earnings per share was 0.26 yuan. The number of shareholders was 4,332, and the top ten shareholders held 57.35 percent of the total share capital.
Jiemian·22dRead more →